Evidence map›Paper›PMID 41599176›Full record

ReviewPharmaceutics2026

Liraglutide and Exenatide in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes.

Paula Santos, Alberto Souza Sá Filho, Vicente Aprigliano, Amanda G Duarte, Natã Alegransi Ribeiro, Katia Marques Lombardo, James Oluwagbamigbe Fajemiroye, Artur Prediger Buchholz, Victor Renault Vaz, Gaspar R Chiappa

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paula SantosGraduate Program in Human Movement and Rehabilitation, Evangelical University of Goiás (UniEVANGÉLICA), Anápolis 75083-515, GO, Brazil.
Alberto Souza Sá FilhoGraduate Program in Human Movement and Rehabilitation, Evangelical University of Goiás (UniEVANGÉLICA), Anápolis 75083-515, GO, Brazil.ORCID 0000-0001-9434-4231
Vicente ApriglianoEscuela de Ingeniería de Construcción y Transporte, Pontificia Universidad Católica de Valparaíso, Avda Brasil 2147, Valparaíso 2362804, Chile.ORCID 0000-0002-7285-2742
Amanda G DuarteDepartment of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, Brazil.
Natã Alegransi RibeiroDepartament of Medicine, Universidade de Passo Fundo, Passo Fundo 99052-900, RS, Brazil.ORCID 0009-0007-7585-0930
Katia Marques LombardoBiomechanics Laboratory, University of the State of Santa Catarina, UDESC Cefid, Florianópolis 88040-900, SC, Brazil.
James Oluwagbamigbe FajemiroyeGraduate Program in Pharmaceutical Sciences, Pharmacology and Therapeutics, Evangelical University of Goiás (UniEVANGÉLICA), Anápolis 75083-515, GO, Brazil.ORCID 0000-0001-7440-7581
Artur Prediger BuchholzDepartment of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, RS, Brazil.
Victor Renault VazMount Auburn Hospital, Harvard Medical School, Cambridge, MA 02138, USA.
Gaspar R ChiappaGraduate Program in Human Movement and Rehabilitation, Evangelical University of Goiás (UniEVANGÉLICA), Anápolis 75083-515, GO, Brazil.ORCID 0000-0002-0440-8404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseasecognitionexenatideGLP-1 receptor agonistsliraglutidemild cognitive impairmentneurodegenerationsystematic review

Identifiers

PMID41599176
PMCPMC12844791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.